Tikvah Katheryn Hayes

Tikvah Katheryn Hayes is an Assistant Professor in the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA) School of Medicine. Her research focuses on oncogene dependency, signal transduction, and therapeutic strategies for cancers, particularly pancreatic and lung tumors. She leads the Hayes Lab, which investigates molecular mechanisms of cancer progression and drug resistance.

• 2024: Author Correction on EGFR extracellular domain mutants and TKI sensitivity
• 2023: Study on lung cancer evolution in Nature
• 2021: ERK-autophagy combination therapy for pancreatic cancer in Cell Reports
• 2020: Research on KRAS epigenetics and RAS protein interactions
• 2019: NRAS-mutant melanoma drug resistance landscape
• 2015: ERK inhibition effects on KRAS pancreatic cancer

Her work spans DNA repair pathways, RAS biology, and genome instability, with collaborations across institutions like UCSD and USC. Key methodologies include functional genomics, protein interaction analysis, and preclinical cancer modeling.